Presentation ACC 2024 Evaluation of a Technology Assisted Web Application to Qualify for Nonprescription Statin Administration Presenter: Steven E. Nissen April 08, 2024
Presentation ACC 2024 PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques Presenter: Seung-Jung Park April 07, 2024
Presentation ACC 2024 Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial Presenter: Alexander Fanaroff April 07, 2024
Presentation ACC 2024 Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk Presenter: Ronald Chi Hang Lee April 06, 2024
Presentation ACC 2024 Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Presenter: Michael J. Koren April 06, 2024
Presentation ACC 2023 A Randomized Trial Assessing The Impact Of Eliminating Copayment For High Value Preventive Medications For Low-income Seniors With Cardiovascular-related Chronic Diseases Presenter: Braden Manns March 06, 2023
Presentation ACC 2022 Long Term Efficacy and Safety of Renal Denervation on Blood Pressure in Patients on Antihypertension Medications: 3-Year Outcomes from the SPYRAL HTN-ON MED Trial Presenter: Felix Mahfoud April 04, 2022
Presentation ACC 2022 A Single Ascending Dose Study of an siRNA Targeting Lipoprotein(a) Presenter: Steven E. Nissen April 04, 2022
Presentation ACC 2020 Evinacumab in Patients with Homozygous Familial Hypercholesterolemia Presenter: Frederick Raal March 30, 2020
Presentation ACC 2020 EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial Presenter: Deepak L. Bhatt March 30, 2020
Presentation ACC 2020 Alirocumab Efficacy And Safety In Adults With Homozygous Familial Hypercholesterolemia (ODYSSEY HoFH) Presenter: Dirk J. Blom March 30, 2020
Presentation ACC 2020 A Randomized Controlled Trial Evaluating the Efficacy and Safety of E-Cigarettes for Smoking Cessation Presenter: Mark Eisenberg March 30, 2020
Presentation ACC 2018 CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes Presenter: Brendan M. Everett March 12, 2018
Presentation ACC 2018 Hospital Readmission Following Perioperative Myocardial Infarction Associated with Non-Cardiac Surgery Presenter: Nathaniel R. Smilowitz March 11, 2018
Presentation ACC 2018 The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome Presenter: Philippe Gabriel Steg March 10, 2018
Presentation ACC 2017 EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Presenter: Jeff Weitz March 20, 2017
Presentation ACC 2015 Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin Presenter: Marc S. Sabatine March 14, 2015
Presentation ACC 2013 Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL) Presenter: David R. Holmes, Jr. March 08, 2013
Presentation ACC 2012 A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial Presenter: Myeong-Ki Hong March 25, 2012